Company
Circadian Therapeutics Limited
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Circadian Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 6
- Dr Mark Raymond Sampson 2020-2022 View profile
- Dr Glenn Robert Leighton 2020-2024 View profile
- Dr Tinashe Brian Chandauka 2020-2021 View profile
- Nigel Anthony Jones 2017-2019 View profile
- Dr Christopher Paul Blackwell 2016-2018 View profile
- Zachary Brit Yerushalmi 2016-2020 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 18/07/2016
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Russell Foster ceased 2016-09-12
75-100% shares, 75-100% voting, appoints directors · notified 2016-07-18 - confirmed: also a director of this company - Oxford Science Enterprises PLC
75-100% shares, 75-100% voting · notified 2016-09-12
Group
- Circadian Therapeutics Limited
is controlled by Russell Foster
Evidence
ceased 75-100% shares, 75-100% voting, appoints directors · notified 2016-07-18, ceased 2016-09-12 · source: Companies House PSC register
Ultimately controlled by Russell Foster.
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Total assets
- £717
- Employees
- 0.01
- Turnover
- Not reported (small or micro-entity accounts)
Filed as Micro-entity accounts.
Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
5 directors on the board
- Nicholas George Dixon-Clegg Director · appointed 2021
- Wallace Lucy Elizabeth Wallace Director · appointed 2025
- Julia Frances Jones Director · appointed 2022
- Dr Michael Frederick Snape Director · appointed 2019
- Russell Foster Director · appointed 2016
Directors past 6 years
- Dr Michael Frederick Snape Director · appointed 2019
- Russell Foster Director · appointed 2016
First-time vs portfolio directors
First-time (2)
- Julia Frances Jones Director · appointed 2022
- Russell Foster Director · appointed 2016
Portfolio (3)
- Nicholas George Dixon-Clegg Director · appointed 2021
- Wallace Lucy Elizabeth Wallace Director · appointed 2025
- Dr Michael Frederick Snape Director · appointed 2019
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 10283353
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data